Alphatec Holdings (ATEC) Revenue Growth (3y) (2013 - 2026)
Alphatec Holdings (ATEC) Revenue Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.14 Bn | 173.84 Bn | 6.27 Bn | 4.63% |
| 2 | Stryker | 128.35 Bn | 125.47 Bn | 3.81 Bn | 8.01% |
| 3 | Medtronic | 107.95 Bn | 98.73 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 68.16 Bn | 66.71 Bn | 3.61 Bn | 15.36% |
| 5 | Edwards Lifesciences | 47.67 Bn | 44.00 Bn | 1.29 Bn | 10.52% |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.17 Bn | 1.98 Bn | 2.92% |
| 7 | Dexcom | 28.45 Bn | 27.33 Bn | 750.30 Mn | 17.14% |
| 8 | Smith & Nephew | 26.83 Bn | 26.25 Bn | - | - |
| 9 | Koninklijke Philips | 25.36 Bn | 22.23 Bn | 2.07 Bn | 0.73% |
| 10 | Alphatec Holdings | 1.35 Bn | 1.21 Bn | 136.48 Mn | 20.75% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.75% |
| Dec 31, 2025 | 26.20% |
| Sep 30, 2025 | 29.81% |
| Jun 30, 2025 | 30.16% |
| Mar 31, 2025 | 33.61% |
| Dec 31, 2024 | 33.71% |
| Sep 30, 2024 | 33.83% |
| Jun 30, 2024 | 32.73% |
| Mar 31, 2024 | 46.41% |
| Dec 31, 2023 | 46.42% |
| Sep 30, 2023 | 42.16% |
| Jun 30, 2023 | 58.02% |
| Mar 31, 2023 | 53.59% |
| Dec 31, 2022 | 48.50% |
| Sep 30, 2022 | 45.44% |
| Jun 30, 2022 | 45.50% |
| Mar 31, 2022 | 42.42% |
| Dec 31, 2021 | 42.91% |
| Sep 30, 2021 | 39.82% |
| Jun 30, 2021 | 41.35% |